Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002196:Capillaries; D002216:Captopril / Q000627:therapeutic use; D003326:Coronary Circulation; D005938:Glucocorticoids / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects*; D017379:Hypertrophy, Left Ventricular / Q000503:physiopathology / Q000517:prevention & control; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D018919:Neovascularization, Physiologic; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013565:Sympatholytics / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D005938:Glucocorticoids; D007093:Imidazoles; D013565:Sympatholytics; D002216:Captopril; C043482:moxonidine; D001241:Aspirin; D008775:Methylprednisolone